Drew Ranieri

Stock Analyst at Morgan Stanley

(1.23)
# 3,520
Out of 4,883 analysts
166
Total ratings
44.94%
Success rate
-12.53%
Average return

Stocks Rated by Drew Ranieri

Organogenesis Holdings
Mar 5, 2025
Maintains: Equal-Weight
Price Target: $4$6
Current: $4.25
Upside: +41.18%
Alphatec Holdings
Dec 2, 2024
Assumes: Equal-Weight
Price Target: $9.5$10
Current: $10.93
Upside: -8.51%
Globus Medical
Dec 2, 2024
Upgrades: Overweight
Price Target: $83$100
Current: $55.97
Upside: +78.67%
Stryker
Dec 2, 2024
Upgrades: Overweight
Price Target: $370$445
Current: $392.51
Upside: +13.37%
SI-BONE
Aug 6, 2024
Maintains: Overweight
Price Target: $21$19
Current: $17.96
Upside: +5.79%
Integra LifeSciences Holdings
Jul 15, 2024
Maintains: Underweight
Price Target: $24$27
Current: $12.75
Upside: +111.76%
Treace Medical Concepts
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $5.5$8
Current: $6.04
Upside: +32.45%
Stevanato Group
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $26$22
Current: $24.35
Upside: -9.65%
NeuroPace
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $9.5$8
Current: $10.21
Upside: -21.65%
Outset Medical
Dec 4, 2023
Maintains: Equal-Weight
Price Target: $75$83
Current: $20.45
Upside: +303.42%
Maintains: Overweight
Price Target: $42$38
Current: $19.67
Upside: +93.19%
Maintains: Equal-Weight
Price Target: $88$96
Current: $75.13
Upside: +27.78%
Maintains: Underweight
Price Target: $28$26
Current: $11.83
Upside: +119.78%
Maintains: Overweight
Price Target: $290$295
Current: $172.95
Upside: +70.57%
Maintains: Equal-Weight
Price Target: $236$280
Current: $116.67
Upside: +139.99%
Maintains: Overweight
Price Target: $11$5
Current: $6.82
Upside: -26.69%
Maintains: Overweight
Price Target: $72$70
Current: $29.69
Upside: +135.77%
Maintains: Equal-Weight
Price Target: $325$300
Current: $534.71
Upside: -43.89%